Company Profile

Company Description

Tyra Biosciences, Inc. is a biotechnology firm focused on developing precision medicines to address treatment-resistant cancers. Leveraging advanced structural biology and computational modeling, the company designs next-generation therapies targeting specific genetic mutations. Its pipeline includes innovative small-molecule inhibitors aimed at overcoming resistance mechanisms in oncology, offering hope for patients with limited treatment options. The company collaborates with leading research institutions to accelerate drug discovery and improve therapeutic outcomes.